[Immunity status in patients with injuries and diseases of the cornea]

Insights

Immunity disorders are common in leukoma, regardless of cause. Pre-keratoplasty treatment should involve immune testing, particularly the leukocyte migration inhibition test with corneal antigen.

Area of Science:

  • Ophthalmology
  • Immunology

Background:

  • Leukoma, a corneal opacity, can result from injuries or diseases.
  • Immunity disorders are frequently observed in patients with leukoma.

Purpose of the Study:

  • To investigate the presence and nature of immunity disorders in patients with leukoma.
  • To identify informative immunologic tests for preoperative assessment before keratoplasty.

Main Methods:

  • Clinical and immunologic examinations were performed on 97 patients with leukoma.
  • The leukocyte migration inhibition test using corneal antigen was evaluated for its informativeness.

Main Results:

  • Clinical and immunologic examinations confirmed immunity disorders in leukoma patients, irrespective of the underlying cause.
  • The leukocyte migration inhibition test with corneal antigen was identified as a highly informative immunologic test.

Conclusions:

  • Immunity disorders are a significant factor in leukoma development and progression.
  • Preoperative assessment of immune status, utilizing tests like the leukocyte migration inhibition test, is crucial for optimizing keratoplasty outcomes.